• Macrophages Prime Pain After Intermittent Hypoxia

  2026-09-11

  This study identifies peripheral macrophages as a necessary immune component of nociceptor priming in mice exposed to chronic intermittent hypoxia, a model of obstructive sleep apnea. By combining behavioral, molecular, and immune analyses with macrophage ablation, the work links recurrent hypoxemia to persistent pain-like sensitization and suggests that peripheral inflammatory signaling may be therapeutically actionable.

• Peripheral Macrophages and Pain in Intermittent Hypoxia

  2026-09-11

  Chivers and colleagues show that chronic intermittent hypoxia, rather than sleep fragmentation alone, recruits peripheral macrophages and produces nociceptor priming in both male and female mice. Their ablation experiment supports a causal role for macrophage-dependent signaling in the transition toward persistent pain, providing a mechanistic link between obstructive sleep apnea-associated hypoxemia and sensory hypersensitivity.

• TTP, m6A, and Schistosomiasis Liver Fibrosis

  2026-09-10

  The reference study identifies tristetraprolin (TTP) as an antifibrotic regulator that promotes WTAP transcription through SMAD2/3, increasing m6A modification and reducing TGF-β1 mRNA stability. Its integrated disease-model, molecular, MeRIP-seq, and proteomic analyses provide a framework for studying how post-transcriptional regulation controls hepatic stellate cell activation.

• DNA Frameworks Improve Enzymatic Oligonucleotide Synthesis

  2026-09-10

  A 2025 Advanced Science study shows that tetrahedral DNA nanostructures can organize primers at a defined nanoscale interface, improving enzyme accessibility, substrate affinity, and enzymatic oligonucleotide synthesis. The framework reduced deletion errors in patterned sequences and supported a 60-nucleotide information-storage construct with a reported stepwise yield of 96.82%.

• AP20187: Programmable Control for Translational Biology

  2026-09-09

  A mechanistic and translational guide to using AP20187 as a chemical inducer of dimerization for conditional gene expression, regulated cell therapy, and metabolic research.

• PreScission Protease (PSP): Practical Tag Cleavage

  2026-09-09

  PreScission Protease (PSP) is a recombinant HRV 3C protease for removing fusion tags from engineered proteins that contain its defined recognition sequence. This dossier-based guide covers construct checks, low-temperature handling, cleavage controls, and troubleshooting; it should not be treated as evidence for live-cell use or for constructs lacking a validated cleavage site.

• Trim71–Ago2 Control of let-7 in ESC Pluripotency

  2026-09-08

  Liu et al. identify a post-transcriptional mechanism linking the RNA-binding protein Trim71 to Ago2 abundance, mature let-7 microRNAs, and embryonic stem cell fate. Their findings support a conserved Trim71–let-7 bistable switch and show that Ago2 translation, rather than Ago2 degradation, is a critical control point for pluripotency.

• SOX7, DNMT3B, and CYGB in Bladder Cancer

  2026-09-08

  Zhang et al. identify SOX7 as a suppressor of bladder cancer progression and connect its activity to transcriptional repression of DNMT3B, altered CYGB promoter methylation, and reduced malignant behavior. The study combines molecular profiling, clinical tissue analysis, cell-based perturbation, and animal experiments, while also proposing a SOX7–CYGB expression score for prognostic assessment.

• Anlotinib hydrochloride: Assay Reliability Guide

  2026-09-07

  This scenario-driven guide shows how Anlotinib hydrochloride, SKU C8688, can improve interpretation of viability, migration, tube-formation, and signaling assays. It connects nanomolar receptor activity with practical controls, concentration selection, and evidence-based product evaluation.

• KU-55933: ATM Kinase Inhibitor Workflows

  2026-09-07

  Use KU-55933 to interrogate ATM-dependent DNA damage signaling, Akt phosphorylation, cell-cycle control, and cancer-cell phenotypes with a practical, assay-first workflow. This guide also shows how to extend ATM perturbation into cGAS, genome-integrity, and L1 retrotransposition studies without overstating what current evidence proves.

• CCG-1423 for Reliable RhoA Pathway Assays

  2026-09-05

  This scenario-based guide explains how CCG-1423, SKU B4897, can help researchers interpret viability, proliferation, and apoptosis data in RhoA-driven models. It covers mechanism, DMSO formulation, protocol planning, cross-domain viral research, and practical product-selection criteria.

• D-N-Acetylgalactosamine Protocol and QC Guide

  2026-09-04

  D-N-Acetylgalactosamine (SKU B7904) provides a defined, high-purity reagent for glycoprotein composition studies, brain heteropolysaccharides analysis, and related glycosylation pathway workflows. It is suitable for aqueous or validated DMSO preparations, but not for ethanol-based protocols or long-term storage of prepared solutions.

• JC-1 Assay Connects Mitochondria to Tumor Angiogenesis

  2026-09-04

  A mechanistic perspective on how mitochondrial membrane potential measurement can strengthen translational studies of LRG1-driven neutrophil dysfunction, NETosis, vascular instability, and treatment resistance in bladder cancer. The article positions the JC-1 Mitochondrial Membrane Potential Assay Kit as a practical ratiometric tool for linking mitochondrial state to apoptosis, mitochondrial function analysis, and therapeutic response while defining the controls and orthogonal assays needed for credible interpretation.

• Apicidin Disrupts Oocyte Quality via Histone Acetylation

  2026-09-03

  A 2026 study shows that Apicidin exposure impairs oocyte meiotic maturation by disrupting spindle assembly, chromosome alignment, actin organization, and histone acetylation. The work connects HDAC-associated epigenetic changes with structural defects, DNA damage, and early apoptosis, providing a focused framework for evaluating the reproductive toxicity of this emerging mycotoxin.

• UK-5099: A Translational Lever for Immunometabolism

  2026-09-03

  UK-5099, also known as PF-1005023, turns mitochondrial pyruvate entry into a controllable variable for mitochondrial metabolism research, immune assays, and glucose-homeostasis studies.

8202 records 1/547 page Next 12345 下5页 Last page